CombiMatrix Pediatric Development Disorders Test Granted Conditional Approval
With recent action by the New York State Department of Health, CombiMatrix now markets two SNP-based genetic analysis tests in New York.
Read MorePosted by Steve Halasey | Jul 24, 2014 | Molecular Diagnostics |
With recent action by the New York State Department of Health, CombiMatrix now markets two SNP-based genetic analysis tests in New York.
Read MorePosted by Jenny Lower | Jul 11, 2014 | Uncategorized |
New products include the Adam DU laboratory balance data collection and analysis software from Adam Software, the CyPlex LS benchtop analyzer from CyVek, and West Nile virus and Eastern equine encephalitis virus molecular standards from Microbiologics.
Read MorePosted by Steve Halasey | Jul 7, 2014 | Research |
The National Institutes of Health has launched a 4-year, $43 million initiative to engage broad expertise in the study and diagnosis of mystery conditions.
Read MorePosted by Steve Halasey | Jun 30, 2014 | Research |
NEJM report offers a primer for doctors’ use of clinical genome and exome sequencing.
Read MorePosted by Steve Halasey | Jun 24, 2014 | Cancer, Molecular Diagnostics, Research |
Horizon Discovery and LGC will partner on project to improve minimally invasive circulating DNA diagnostic assays, supporting implementation of stratified and personalized intervention strategies.
Read More